Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Ascelia Pharma AB

Closing information (x1000 NOK)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 2,450 More Arrow 3,751 Less Arrow 1,964
Earnings before taxes -111,035 Less Arrow -125,953 Less Arrow -126,314
EBITDA -111,297 Less Arrow -138,066 More Arrow -133,525
Total assets 88,207 More Arrow 206,747 More Arrow 325,230
Current assets 29,314 More Arrow 152,168 More Arrow 267,807
Current liabilities 12,732 More Arrow 35,488 Less Arrow 24,484
Equity capital 75,297 More Arrow 171,077 More Arrow 300,207
- share capital 35,325 Less Arrow 32,985 More Arrow 33,719
Employees (average) 23 Less Arrow 22 Less Arrow 20

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 85.4% Less Arrow 82.7% More Arrow 92.3%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -123.1% More Arrow -59.1% More Arrow -38.2%
Current ratio 230.2% More Arrow 428.8% More Arrow 1093.8%
Return on equity (ROE) -147.5% More Arrow -73.6% More Arrow -42.1%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 1 More Arrow 2 More Arrow 9
Chg. No. of employees % 5% More Arrow 10% More Arrow 82%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.